Jump to content

User:Mr. Ibrahem/Miglitol

From Wikipedia, the free encyclopedia
Mr. Ibrahem/Miglitol
Structural diagram of miglitol
Clinical data
Trade namesGlyset
AHFS/Drugs.comMonograph
MedlinePlusa601079
License data
Pregnancy
category
  • AU: B3
Routes of
administration
By mouth (tablets)
Drug classα-glucosidase inhibitor[1]
Legal status
Legal status
Pharmacokinetic data
BioavailabilityDose-dependent
Protein bindingNegligible (<4.0%)
MetabolismNil
Elimination half-life2 hours
ExcretionKidney (95%)
Identifiers
  • (2R,3R,4R,5S)-1-(2-Hydroxyethyl)-2-(hydroxymethyl)
    piperidine-3,4,5-triol
Chemical and physical data
FormulaC8H17NO5
Molar mass207.226 g·mol−1
3D model (JSmol)
Density1.458 g/cm3
Melting point114 °C (237 °F)
  • OCCN1[C@@H]([C@@H](O)[C@H](O)[C@@H](O)C1)CO
  • InChI=1S/C8H17NO5/c10-2-1-9-3-6(12)8(14)7(13)5(9)4-11/h5-8,10-14H,1-4H2/t5-,6+,7-,8-/m1/s1 checkY
  • Key:IBAQFPQHRJAVAV-ULAWRXDQSA-N checkY
  (verify)

Miglitol, sold under the brand name Glycet, is a medication used to treat type 2 diabetes.[1] It is taken by mouth.[1] It is used together with diet and exercise.[1]

Common side effects include diarrhea, abdominal pain, and increased intestinal gas.[1] Well there is no evidence of harm in pregnancy, such use has not been well studied.[2] It is an α-glucosidase inhibitor which decreases the break down complex carbohydrates into glucose.[1]

Miglitol was approved for medical use in the United States in 1996.[1] It is available as a generic medication.[3] In the United States it costs about 24 USD per month as of 2021.[3]

References[edit]

  1. ^ a b c d e f g h i j "Miglitol Monograph for Professionals". Drugs.com. Archived from the original on 14 August 2020. Retrieved 18 November 2021.
  2. ^ "Miglitol (Glyset) Use During Pregnancy". Drugs.com. Archived from the original on 3 December 2020. Retrieved 18 November 2021.
  3. ^ a b "Miglitol Prices, Coupons & Savings Tips - GoodRx". GoodRx. Retrieved 18 November 2021.